Tempus AI (NASDAQ:TEM) Trading Up 3% - Should You Buy?

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) was up 3% during trading on Monday . The stock traded as high as $74.83 and last traded at $73.45. Approximately 4,334,236 shares changed hands during mid-day trading, a decline of 38% from the average daily volume of 6,996,176 shares. The stock had previously closed at $71.28.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on TEM. Guggenheim reiterated a "buy" rating on shares of Tempus AI in a research report on Tuesday, February 25th. William Blair restated a "market perform" rating on shares of Tempus AI in a research report on Tuesday, February 25th. JPMorgan Chase & Co. downgraded Tempus AI from an "overweight" rating to a "neutral" rating and boosted their target price for the stock from $50.00 to $55.00 in a report on Tuesday, February 25th. BTIG Research began coverage on Tempus AI in a research note on Monday, April 21st. They issued a "buy" rating and a $60.00 price target for the company. Finally, Needham & Company LLC reiterated a "buy" rating and set a $70.00 price objective on shares of Tempus AI in a research report on Wednesday, May 7th. Six equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $63.42.

Tempus AI Stock Performance

The business has a 50 day moving average price of $55.90 and a two-hundred day moving average price of $52.31. The stock has a market cap of $12.46 billion and a P/E ratio of -9.22. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17.

Tempus AI (NASDAQ:TEM - Get Free Report) last announced its quarterly earnings results on Tuesday, May 6th. The company reported ($0.24) EPS for the quarter, beating analysts' consensus estimates of ($0.27) by $0.03. The firm had revenue of $255.74 million for the quarter, compared to the consensus estimate of $248.13 million. Tempus AI's revenue was up 75.4% compared to the same quarter last year. On average, sell-side analysts forecast that Tempus AI, Inc. will post -6.15 earnings per share for the current fiscal year.

Insider Buying and Selling at Tempus AI

In other news, Director Theodore Leonsis sold 205,847 shares of the stock in a transaction that occurred on Wednesday, June 11th. The stock was sold at an average price of $67.66, for a total value of $13,927,608.02. Following the sale, the director now directly owns 15,511 shares in the company, valued at approximately $1,049,474.26. This represents a 92.99% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Wayne A.I. Frederick sold 3,000 shares of the firm's stock in a transaction on Monday, March 31st. The stock was sold at an average price of $45.54, for a total value of $136,620.00. Following the transaction, the director now owns 26,514 shares in the company, valued at $1,207,447.56. The trade was a 10.16% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 344,745 shares of company stock worth $21,819,358 over the last ninety days. Company insiders own 27.60% of the company's stock.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Victory Capital Management Inc. purchased a new position in Tempus AI during the 4th quarter worth $216,000. Wells Fargo & Company MN increased its holdings in Tempus AI by 13.2% during the 4th quarter. Wells Fargo & Company MN now owns 2,384 shares of the company's stock worth $80,000 after purchasing an additional 278 shares during the period. SeaCrest Wealth Management LLC purchased a new position in Tempus AI during the 1st quarter worth $535,000. ProShare Advisors LLC purchased a new position in Tempus AI during the 4th quarter worth $244,000. Finally, Avanza Fonder AB boosted its position in Tempus AI by 15.8% during the 1st quarter. Avanza Fonder AB now owns 41,005 shares of the company's stock valued at $2,047,000 after acquiring an additional 5,591 shares in the last quarter. 24.22% of the stock is currently owned by hedge funds and other institutional investors.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.